Why Sarepta Therapeutics, Cbeyond, and Advanced Micro Devices Are Today's 3 Best Stocks

The S&P 500 makes it a perfect five-for-five as Sarepta Therapeutics, Cbeyond, and Advanced Micro Devices all skyrocket higher.

Apr 21, 2014 at 5:15PM

Let's make that a perfect five-for-five for the broad-based S&P 500 (SNPINDEX:^GSPC) since the tumultuous two-day tumble that wiped out about 3% of the index's value a week and a half ago.


Today's rally featured a little bit of everything, including better than expected earnings reports driving stocks higher, merger and acquisition activity, rumors fueling the desire for companies to take on risk, and even a solitary piece of positive economic data.

That last item was the release of the Conference Board's leading economic indicators for March, which rose 0.8%, up from a gain of 0.5% in February. This higher than expected result could signify that bountiful growth could be right around the corner for the U.S. economy; but investors might also take this strength with a grain of salt considering that this is a big rebound from the January swoon created by the exceptionally cold weather. Still, growth is growth and investors seem pretty pleased with March's improvement over February.

One thing to keep in mind is that housing data has been a crutch for the market over the past couple of months, and we're going to get a closer look at existing home sales tomorrow and hew homes sales for March on Wednesday. So this five-day winning streak may soon come to an end.

Today, though, went to the bulls with the S&P 500 climbing by 7.04 points (0.38%) to close at 1,871.89, essentially wiping away the entirety of the S&P 500's two-day drop for the week ending April 11.

Leading all players to the upside today was clinical-stage biopharmaceutical company Sarepta Therapeutics (NASDAQ:SRPT), which surged 39.3% after announcing plans to file for a new drug application for lead drug eteplirsen later this year. Eteplirsen is formulated to treat a specific type of Duchenne muscular dystrophy (it covers about 13% of all cases), and Sarepta was told last year by the Food and Drug Administration that its current phase 2 data would be insufficient for an early new drug application filing.

Srpt Cowen
Source: Sarepta Therapeutics, Cowen Healthcare conference March 2014.

Today, though, the FDA appeared to have changed its tune, with Sarepta announcing the potential to file an NDA this year. A quicker approval could mean less cash burned, which is a big positive for Sarepta. But you should also keep in mind that GlaxoSmithKline and Prosensa were in a similar situation with previous DMD hopeful drisapersen last year and their therapy flopped badly in a larger study. As such, I'm perfectly happy watching Sarepta as an observer, not a shareholder, at the moment.

Not tracking far behind Sarepta was cloud-based service and network communications provider Cbeyond (NASDAQ:CBEY), which rocketed 38.6% higher after agreeing to be purchased by privately held Birch Communications for approximately $323 million -- between $9.97 and $10 per share in cash, depending on how many stock awards are issued to employees following this agreement. The deal isn't a huge shock as Cbeyond has been looking at innovative ways to boost shareholder value for the past six months, including a possible sale. With ongoing losses and a shrinking top line, I believe shareholders should count their blessings given today's premium. It also suggests that weaker plays in the cloud sector may still have hope that a white knight similar to Birch Communications will save them.

Amd Phenom Ii

Source: Mike Babcock, Wikimedia Commons.

Lastly, chipmaker Advanced Micro Devices (NASDAQ:AMD), advanced 11.7% after reporting its first-quarter operating results after the closing bell on Thursday. For the quarter, revenue rose a robust 28% to $1.4 billion, with earnings per share of $0.02, despite flat quarter-over-quarter margins. By comparison, Wall Street only expected breakeven EPS on $1.34 billion in revenue. While the results were better than expected, AMD still reported a 12% year-over-year decline in computing solutions revenue and flat microprocessor average selling prices. AMD's guidance, though, was strong, calling for low single-digit sequential quarterly revenue growth and signaling that the PC market and its graphics division may be stabilizing. I see plenty of value in AMD at these levels, but would caution value investors to understand that this stock isn't without a number of risks as well.

Sarepta, Cbeyond, and AMD all soared today, but even they could struggle to keep pace with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of fool.com.

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to www.fool.com/beginners, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at www.fool.com/podcasts.

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers